AS

Asha Srivastava

Active Director Additional Director DIN 08301293
DIN 08301293 First appointment Dec 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Asha Srivastava

Data last updated:

Asha Srivastava is an Additional Director at Celosia Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Celosia Pharmaceutical Private Limited reported revenue of ₹2.51 Cr (FY 2025).

DIN 08301293
Primary Designation Additional Director
Industry Pharma
First Appointment 11 Dec 2018
Oldest Company Age 10 yrs
Largest company Celosia Pharmaceutical Private Limited · ₹2.51 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director11 Dec 20182016₹2.51 Cr (FY 2025)Active

Board colleagues of Asha Srivastava

NameDINCompanyDesignation
Ajay Kumar Srivastava06611954Celosia Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Celosia Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Asha Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asha Srivastava

Asha Srivastava currently holds 1 directorship: Celosia Pharmaceutical Private Limited (Additional Director, since 11 Dec 2018, revenue ₹2.51 Cr (FY 2025)).

Asha Srivastava was first appointed on 11 Dec 2018 as Additional Director at Celosia Pharmaceutical Private Limited.

The current boards of Asha Srivastava's companies include Ajay Kumar Srivastava (Celosia Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available